> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Extends Research with CN Bio for 3 Years
- URL: https://www.fdaweb.com/fda-extends-research-with-cn-bio-for-3-years/
- Published: 2021-05-05T12:00:00.000Z
- Updated: 2026-09-14T16:57:42.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5149255

FDA has extended for three years its research collaboration with CN Bio, which will now focus on exploring CN Bio’s “lung-on-a-chip” using the PhysioMimix platform to appraise the system’s use for the evaluation of inhaled drug products and assessing additional applications for CN Bio’s liver model.

The company [says](https://www.marketwatch.com/press-release/the-fda-expands-collaboration-with-cn-bio-to-investigate-lung-on-a-chip-model-for-inhaled-drug-evaluation-applications-2021-05-05?tesla=y&ref=fdaweb.com) the extension follows a successful four-year collaboration that culminated in a co-publication demonstrating the advanced performance of the company’s liver-on-a-chip platform.